Dr Scott J Turner | Specialist Plastic Surgeon (FRACS)
Key Takeaways
- Breast implant illness describes a cluster of systemic symptoms some patients experience after augmentation and attribute to their implants. The symptoms are real; the mechanism is still being worked out.
- The most frequently reported are fatigue, problems with memory or concentration (“brain fog”), joint and muscle pain, hair loss, weight changes, and anxiety or low mood. More than 50 different symptoms have been described in the literature.
- It is not a formal diagnosis with a specific test. It is reached by excluding other causes, which is why a proper workup comes before any decision about surgery.
- Symptoms have been reported with all implant types regardless of filling, shape or surface, and onset ranges from immediately after surgery to decades later.
- Explant is the intervention with the most consistent reported improvement, but for systemic symptoms that improvement is typically moderate rather than complete, and it cannot be predicted for an individual. Studies with longer follow-up report more modest results than those measured at a few months.
- The evidence does not establish en-bloc capsulectomy as better than less extensive capsule removal for symptom improvement. The surgical approach should be a clinical decision, not one driven by patient forums.
Breast implant illness is one of the most contested topics in modern breast surgery. Patients report a constellation of symptoms they attribute to their implants, often improving after removal. The medical literature has been slow to accept it as a discrete diagnosis, because the symptom list is broad, the proposed mechanism is uncertain, and rigorous controlled studies are hard to design. Both positions are held in good faith, and the reasonable view sits between them: the symptoms are real, the mechanism is still being worked out, the explant data is promising, and the conversation has moved well beyond the dismissive framing of a decade ago.
This guide covers what is currently understood: the symptom patterns and what they are called, what the regulators and the recent studies say, whether removal improves symptoms, and how assessment works in Australia. The surgical pathway is on the breast implant revision and removal page, and this post sits within the broader account of breast augmentation risks and complications.
What breast implant illness is
Breast implant illness refers to a group of systemic symptoms some patients experience after implant surgery and attribute to the implants. You will also see it called silicone implant illness or breast implant disease, and it overlaps with a broader research framework called ASIA, autoimmune/inflammatory syndrome induced by adjuvants, which proposes that silicone and other biomaterials may contribute to immune dysregulation in susceptible people. ASIA remains contested, and no validated diagnostic biomarker exists for it.
It is not a formal diagnosis with a specific cause and a specific test. It is recognised as a phenomenon deserving serious attention, and both the FDA in the United States and the TGA in Australia now reference it directly in their patient information.
Understanding why the diagnostic status is unsettled matters more than treating it as scepticism. A formal diagnosis usually rests on a defining feature: a specific test result, a characteristic finding, or a symptom pattern seen consistently enough to be codified. Breast implant illness has none of those, because the symptoms overlap heavily with common conditions, no test distinguishes it, and the studies that would settle the question are difficult to run well, since the honest comparison would require following large matched groups of women with and without implants over many years. The absence of a codified diagnosis is a statement about the evidence, not a judgement that the symptoms are imagined.
The symptoms most commonly reported
The FDA names the core cluster as fatigue, problems with memory or concentration (“brain fog”), joint and muscle pain, hair loss, weight changes, and anxiety or depression. It states plainly that these symptoms and what causes them are poorly understood.
The FDA compiles these from medical device reports submitted by patients and clinicians. Fatigue is the most frequently reported, followed by joint-related complaints, anxiety, brain fog, hair loss and depression. Reports of this kind are useful for detecting a signal, but they cannot establish how common the condition is, because there is no denominator: nobody knows how many women with implants have no symptoms at all.
Beyond that core list, more than 50 patient-reported symptoms have been described in association with silicone breast implants, and no specific diagnostic definition exists. The wider set includes sleep disturbance, dry eyes and dry mouth, rashes and skin sensitivity, headaches, gastrointestinal complaints, palpitations, low-grade fever, morning stiffness, pins and needles, and recurrent infections. Most patients have a personal cluster of perhaps five to ten symptoms rather than the whole list.
On timing, symptoms have been reported anywhere from immediately after implantation to decades later. Published studies report a median of four to ten years between implantation and symptom onset. There is no window after which you are considered clear.
On implant type, the FDA states that these symptoms have been reported with all types of breast implants, regardless of filling, shape or surface characteristics. Silicone and saline are both represented.
The non-specific nature of the list is part of why the condition has been difficult to characterise, since each individual symptom has many possible causes. What makes the pattern distinctive is the cluster, the timing relative to surgery, and the reported improvement after removal.
What is known about causes
The honest answer is that it is not known, and the picture is likely multifactorial rather than a single mechanism.
Proposed mechanisms include chronic foreign-body inflammation, silicone gel bleed and particulate migration, macrophage activation, cytokine dysregulation, and bacterial biofilm on the implant surface. Individual susceptibility, whether genetic or immunological, may help explain why most patients have no systemic symptoms after augmentation while a smaller subset develop the pattern.
None of these is established. Many historical claims about causes have not held up to scrutiny, so speculation about specific factors should be weighed cautiously and should not drive clinical decisions on its own.
Do symptoms go away after explant?
This is the question most patients arrive with, and the answer is that many improve, not all do, and the size of the improvement depends partly on how long you measure for.
The most frequently cited study is a 2023 retrospective cohort published in Cureus by Serena and colleagues, which followed 229 patients who underwent explantation with total capsulectomy between 2018 and 2021. Average symptom scores fell from 3.5 before surgery to 1.9 afterward on a five-point scale, and patients had an average of 2.8 individual symptoms eliminated. That is a substantial reported improvement in a reasonably large series.
A 2026 systematic review and meta-analysis in JPRAS Open by Cuenca-Pardo and colleagues, covering 20 publications and 2,280 patients, tempers that picture in two ways worth knowing.
First, on how long improvement was measured for. Around 65% of the studies reporting complete resolution had a mean follow-up of only 3.4 months, while studies following patients beyond twelve months reported more stable but lower improvement scores. The very high resolution figures circulating online are often measured early.
Second, on the size of the improvement. For patients whose surgery was for systemic symptoms, the review found improvement was typically moderate and frequently incomplete, rated around three on a five-point scale. Patients operated on for objectively identifiable problems, such as granulomas or confirmed organ involvement, did substantially better, at the top of that scale. That difference is itself informative: outcomes are most predictable when there is something objective to find.
The review is also explicit about the limitation running through all of this evidence. No study has compared patients who had their implants removed against symptomatic patients who kept them, so causation cannot be separated from the natural course of the symptoms, regression to the mean, or the effect of having had surgery at all.
The pattern of individual response is worth setting out plainly. Some patients report improvement within days to weeks, which is faster than a purely immune mechanism would predict and has led researchers to consider whether expectation and the resolution of anxiety play a part alongside any physical change. Others improve gradually over several months. A smaller group notice little change, and for them the workup that preceded surgery matters, because it is what identifies whether an alternative and treatable cause was present all along.
None of this means the improvement reported by the majority is not real. It means the response is variable, it cannot be promised to an individual, and a surgeon who guarantees resolution is overstating what the evidence supports.
On surgical approach, the evidence is firmer than patient communities often suggest, and it points the other way. A 2024 study by Glicksman and colleagues in the Aesthetic Surgery Journal reported symptom improvement after explantation with no capsulectomy at all, and comparative work has found intact total, total and partial capsulectomy producing similar symptom improvement with no statistical difference between them. This is not an absence of evidence that en-bloc is better; it is evidence that the approaches perform comparably for symptoms. The choice depends on capsule thickness, evidence of capsular pathology, implant integrity and individual factors, and it is a conversation to have with your surgeon rather than a decision to make from a forum. The terminology and technical detail are covered in the en-bloc and capsulectomy guide, and the recovery side in recovery after breast implant removal.
When the symptoms are not breast implant illness
Because breast implant illness is reached by excluding other causes, this section does more work than it might appear to. A meaningful proportion of patients who present with concerns have a different explanation, including identifiable implant complications and unrelated medical conditions.
Implant-related causes. Capsular contracture can cause breast pain and distortion that may be misattributed to systemic illness; its presentation and grading are covered in the capsular contracture guide. Silent rupture of a silicone implant can cause local symptoms and, in some patients, systemic responses, and is detectable on MRI, which is one reason imaging surveillance is recommended. BIA-ALCL, a rare cancer linked to certain textured implants, typically presents with a delayed seroma rather than the systemic symptom pattern, and is covered in the BIA-ALCL guide.
Unrelated conditions with overlapping symptoms. Fatigue alone has many possible causes, including anaemia, thyroid dysfunction and other endocrine disorders, sleep disturbance, cardiopulmonary disease, infection, inflammatory and rheumatological disease, depression and anxiety, medication effects, and ordinary life circumstances. Conditions that most often account for the fuller pattern include autoimmune diseases such as rheumatoid arthritis, lupus and Sjögren’s syndrome, thyroid disease, fibromyalgia, chronic fatigue syndrome, the perimenopausal transition, and depression with physical features.
A thorough medical workup before attributing symptoms to the implants is important, and some patients with persistent unexplained symptoms benefit from assessment by a rheumatologist, endocrinologist or immunologist before considering removal. That is not a delaying tactic. It is the only way the diagnosis can be reached at all, and it protects patients from having surgery that was never going to address the cause.
Assessment in Australia
Most of the patient information available on this topic is American, and the pathway here differs in several respects worth knowing.
Start with your GP. A general workup can identify alternative explanations and provides a baseline, typically covering inflammatory markers, thyroid function, full blood count, hormonal status, vitamin levels and autoimmune screening. A GP referral is also required before an initial surgical consultation under the current Medical Board framework, so this step is both clinically and procedurally necessary.
Imaging. MRI is the most reliable test for silent rupture in silicone implants, ultrasound can identify capsular issues and seromas, and routine mammographic screening should continue at the recommended interval regardless.
Specialist referral where indicated. A plastic surgeon can assess the implants, the capsule and any local complication. What a plastic surgeon cannot do is diagnose or exclude systemic autoimmune disease, which is why rheumatology or immunology input is sometimes the right next step rather than surgery.
The Australian Breast Device Registry. The ABDR is a Commonwealth-funded registry managed by Monash University that records breast device surgeries in Australia and tracks safety, performance and complication trends. If you do not know what was implanted, when, or by whom, you can request your own registry record, and that information matters: implant type, surface, date and any prior revision all bear on the assessment. Patients who have moved between surgeons or cities often find this is the fastest route to a complete history.
What a good consultation looks like. It should cover your symptom timeline, a physical examination, a review of your imaging, and a frank discussion of options. What it should not include is pressure to decide quickly, dismissal of your symptoms, or a specific procedure recommended before a full assessment. If a consultation feels like any of those, seek a second opinion.
Frequently asked questions
What are the symptoms of breast implant illness?
The most frequently reported are fatigue, problems with memory or concentration often described as brain fog, joint and muscle pain, hair loss, weight changes, and anxiety or low mood. More than 50 symptoms have been described in the literature, and most patients have a personal cluster of around five to ten rather than the whole list. The symptoms are non-specific, which is why assessment focuses on excluding other causes.
Does explant fix breast implant illness?
Many patients report meaningful improvement, but not all do, and resolution cannot be promised. A 2023 cohort of 229 patients found average symptom scores fell from 3.5 to 1.9 after explantation with total capsulectomy. A 2026 systematic review of 20 studies and 2,280 patients found that improvement for systemic symptoms was typically moderate rather than complete, and that studies reporting the highest resolution rates had usually measured at around three months. Some patients improve within weeks, others over months, and a smaller group notice little change.
Is breast implant illness a recognised diagnosis?
Not as a formal diagnosis with defined criteria and a confirmatory test. It is recognised as a genuine phenomenon by the FDA and the TGA, both of which reference it in their patient information. In practice it is a diagnosis of exclusion, reached after other causes have been investigated and ruled out.
Do certain implant types cause it?
The FDA states that these symptoms have been reported with all types of breast implants, regardless of filling, shape or surface characteristics, and both silicone and saline are represented in the reports. No implant type has been established as safe from it or as causing it.
How long after surgery do symptoms start?
There is no fixed window. Reports range from immediately after implantation to decades later, with published studies reporting a median of four to ten years. Onset years after uneventful surgery is common rather than unusual.
Dr Scott J Turner is a Specialist Plastic Surgeon (FRACS) consulting in Sydney. A GP referral is required before an initial surgical consultation under the current Medical Board of Australia framework. If you have implants and symptoms that concern you, the assessment matters more than the decision about surgery, because what it identifies determines whether removal is likely to help at all. To have that worked through properly, contact the practice to arrange a consultation. Bringing any original implant records, operation notes and recent imaging assists the assessment.
